Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors

Ganepola A P Ganepola, Robert M. Mazziotta, Dilendra Weeresinghe, Georgia A. Corner, Cheryl J. Parish, David H. Chang, Niall C. Tebbutt, Carmel Murone, Naseem Ahmed, Leonard H. Augenlicht, John M. Mariadason

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The objective of this study was to gain insights into the biological basis of the metastatic process by characterizing the gene expression differences between primary and metastatic colon cancers. Recent studies have demonstrated that few new mutational changes are acquired during the metastatic progression of colon tumors [Jones et al., Proc Natl Acad Sci USA 105 (11): 4283-4288, 2008]. However, the extent to which epigenetic and transcriptional changes occur between primary and metastatic colon cancer remains unknown. We approached these issues using Affymetrix microarrays to assess the similarities and differences in gene expression profiles between macro-dissected primary and metastatic colon tumors. Unexpectedly, we found that expression of a number of cell proliferation markers were reduced in the liver metastases of colon tumors when compared to primary tumors. This finding was validated by immunohistochemical staining of Ki67 and Cyclin D1 in Formalin-Fixed Paraffin-Embedded (FFPE) section of the same samples, and in an independent cohort of FFPE matched tumor and metastatic tissue samples. These results indicate that significant transcriptional differences exist between primary and metastatic colon tumors, and demonstrate that metastatic lesions have a lower proliferative rate compared to primary tumors. These findings may have implications for interpreting differences in response rates between primary and metastatic lesions and suggest that measurement of expression-based biomarkers in metastatic tissue will be most informative for understanding the basis of response of metastatic tumors to therapeutic intervention.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalClinical and Experimental Metastasis
Volume27
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Gene Expression Profiling
Colonic Neoplasms
Neoplasms
Colon
Paraffin
Formaldehyde
Cyclin D1
Transcriptome
Epigenomics
Biomarkers
Cell Proliferation
Staining and Labeling
Neoplasm Metastasis
Gene Expression
Liver

Keywords

  • Gene expression of colon tumor
  • Gene expression profiling
  • Immunohistochemical validation
  • Metastatic colorectal cancer
  • Metastatic process
  • Metastatic proliferation
  • Microarray analysis of colon cancer
  • Primary and metastatic colon cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ganepola, G. A. P., Mazziotta, R. M., Weeresinghe, D., Corner, G. A., Parish, C. J., Chang, D. H., ... Mariadason, J. M. (2010). Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors. Clinical and Experimental Metastasis, 27(1), 1-9. https://doi.org/10.1007/s10585-009-9295-2

Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors. / Ganepola, Ganepola A P; Mazziotta, Robert M.; Weeresinghe, Dilendra; Corner, Georgia A.; Parish, Cheryl J.; Chang, David H.; Tebbutt, Niall C.; Murone, Carmel; Ahmed, Naseem; Augenlicht, Leonard H.; Mariadason, John M.

In: Clinical and Experimental Metastasis, Vol. 27, No. 1, 01.2010, p. 1-9.

Research output: Contribution to journalArticle

Ganepola, GAP, Mazziotta, RM, Weeresinghe, D, Corner, GA, Parish, CJ, Chang, DH, Tebbutt, NC, Murone, C, Ahmed, N, Augenlicht, LH & Mariadason, JM 2010, 'Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors', Clinical and Experimental Metastasis, vol. 27, no. 1, pp. 1-9. https://doi.org/10.1007/s10585-009-9295-2
Ganepola, Ganepola A P ; Mazziotta, Robert M. ; Weeresinghe, Dilendra ; Corner, Georgia A. ; Parish, Cheryl J. ; Chang, David H. ; Tebbutt, Niall C. ; Murone, Carmel ; Ahmed, Naseem ; Augenlicht, Leonard H. ; Mariadason, John M. / Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors. In: Clinical and Experimental Metastasis. 2010 ; Vol. 27, No. 1. pp. 1-9.
@article{0b5d37644a4a47c39453622e4adfbd20,
title = "Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors",
abstract = "The objective of this study was to gain insights into the biological basis of the metastatic process by characterizing the gene expression differences between primary and metastatic colon cancers. Recent studies have demonstrated that few new mutational changes are acquired during the metastatic progression of colon tumors [Jones et al., Proc Natl Acad Sci USA 105 (11): 4283-4288, 2008]. However, the extent to which epigenetic and transcriptional changes occur between primary and metastatic colon cancer remains unknown. We approached these issues using Affymetrix microarrays to assess the similarities and differences in gene expression profiles between macro-dissected primary and metastatic colon tumors. Unexpectedly, we found that expression of a number of cell proliferation markers were reduced in the liver metastases of colon tumors when compared to primary tumors. This finding was validated by immunohistochemical staining of Ki67 and Cyclin D1 in Formalin-Fixed Paraffin-Embedded (FFPE) section of the same samples, and in an independent cohort of FFPE matched tumor and metastatic tissue samples. These results indicate that significant transcriptional differences exist between primary and metastatic colon tumors, and demonstrate that metastatic lesions have a lower proliferative rate compared to primary tumors. These findings may have implications for interpreting differences in response rates between primary and metastatic lesions and suggest that measurement of expression-based biomarkers in metastatic tissue will be most informative for understanding the basis of response of metastatic tumors to therapeutic intervention.",
keywords = "Gene expression of colon tumor, Gene expression profiling, Immunohistochemical validation, Metastatic colorectal cancer, Metastatic process, Metastatic proliferation, Microarray analysis of colon cancer, Primary and metastatic colon cancer",
author = "Ganepola, {Ganepola A P} and Mazziotta, {Robert M.} and Dilendra Weeresinghe and Corner, {Georgia A.} and Parish, {Cheryl J.} and Chang, {David H.} and Tebbutt, {Niall C.} and Carmel Murone and Naseem Ahmed and Augenlicht, {Leonard H.} and Mariadason, {John M.}",
year = "2010",
month = "1",
doi = "10.1007/s10585-009-9295-2",
language = "English (US)",
volume = "27",
pages = "1--9",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors

AU - Ganepola, Ganepola A P

AU - Mazziotta, Robert M.

AU - Weeresinghe, Dilendra

AU - Corner, Georgia A.

AU - Parish, Cheryl J.

AU - Chang, David H.

AU - Tebbutt, Niall C.

AU - Murone, Carmel

AU - Ahmed, Naseem

AU - Augenlicht, Leonard H.

AU - Mariadason, John M.

PY - 2010/1

Y1 - 2010/1

N2 - The objective of this study was to gain insights into the biological basis of the metastatic process by characterizing the gene expression differences between primary and metastatic colon cancers. Recent studies have demonstrated that few new mutational changes are acquired during the metastatic progression of colon tumors [Jones et al., Proc Natl Acad Sci USA 105 (11): 4283-4288, 2008]. However, the extent to which epigenetic and transcriptional changes occur between primary and metastatic colon cancer remains unknown. We approached these issues using Affymetrix microarrays to assess the similarities and differences in gene expression profiles between macro-dissected primary and metastatic colon tumors. Unexpectedly, we found that expression of a number of cell proliferation markers were reduced in the liver metastases of colon tumors when compared to primary tumors. This finding was validated by immunohistochemical staining of Ki67 and Cyclin D1 in Formalin-Fixed Paraffin-Embedded (FFPE) section of the same samples, and in an independent cohort of FFPE matched tumor and metastatic tissue samples. These results indicate that significant transcriptional differences exist between primary and metastatic colon tumors, and demonstrate that metastatic lesions have a lower proliferative rate compared to primary tumors. These findings may have implications for interpreting differences in response rates between primary and metastatic lesions and suggest that measurement of expression-based biomarkers in metastatic tissue will be most informative for understanding the basis of response of metastatic tumors to therapeutic intervention.

AB - The objective of this study was to gain insights into the biological basis of the metastatic process by characterizing the gene expression differences between primary and metastatic colon cancers. Recent studies have demonstrated that few new mutational changes are acquired during the metastatic progression of colon tumors [Jones et al., Proc Natl Acad Sci USA 105 (11): 4283-4288, 2008]. However, the extent to which epigenetic and transcriptional changes occur between primary and metastatic colon cancer remains unknown. We approached these issues using Affymetrix microarrays to assess the similarities and differences in gene expression profiles between macro-dissected primary and metastatic colon tumors. Unexpectedly, we found that expression of a number of cell proliferation markers were reduced in the liver metastases of colon tumors when compared to primary tumors. This finding was validated by immunohistochemical staining of Ki67 and Cyclin D1 in Formalin-Fixed Paraffin-Embedded (FFPE) section of the same samples, and in an independent cohort of FFPE matched tumor and metastatic tissue samples. These results indicate that significant transcriptional differences exist between primary and metastatic colon tumors, and demonstrate that metastatic lesions have a lower proliferative rate compared to primary tumors. These findings may have implications for interpreting differences in response rates between primary and metastatic lesions and suggest that measurement of expression-based biomarkers in metastatic tissue will be most informative for understanding the basis of response of metastatic tumors to therapeutic intervention.

KW - Gene expression of colon tumor

KW - Gene expression profiling

KW - Immunohistochemical validation

KW - Metastatic colorectal cancer

KW - Metastatic process

KW - Metastatic proliferation

KW - Microarray analysis of colon cancer

KW - Primary and metastatic colon cancer

UR - http://www.scopus.com/inward/record.url?scp=74849137748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74849137748&partnerID=8YFLogxK

U2 - 10.1007/s10585-009-9295-2

DO - 10.1007/s10585-009-9295-2

M3 - Article

VL - 27

SP - 1

EP - 9

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 1

ER -